| |
| |
|
| Insider
Information: |
Wilson Marc |
| Relationship: |
CFO |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
120,986 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,467,335 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
120,986 |
|
|
| Total
Value |
$5,467,335 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 112.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cidara Therapeutics, Inc. |
CDTX |
Chief Accounting Officer |
2017-09-18 |
10,356 |
2017-09-18 |
0 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
CFO |
2024-03-19 |
110,630 |
2022-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2024-03-19 |
4 |
AS |
$42.91 |
$297,881 |
D/D |
(6,942) |
110,630 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2024-03-18 |
4 |
D |
$38.14 |
$151,912 |
D/D |
(3,983) |
117,572 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
25,500 |
121,555 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2024-01-02 |
4 |
AS |
$35.47 |
$354,700 |
D/D |
(10,000) |
96,055 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2024-01-02 |
4 |
OE |
$9.28 |
$92,800 |
D/D |
10,000 |
106,055 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2023-06-20 |
4 |
S |
$19.96 |
$617,403 |
D/D |
(30,922) |
95,158 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2023-06-20 |
4 |
OE |
$9.28 |
$185,600 |
D/D |
20,000 |
115,158 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2023-03-16 |
4 |
D |
$17.12 |
$28,522 |
D/D |
(1,666) |
106,080 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,200 |
107,746 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
CFO |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
81,618 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Accounting Officer |
• – – |
2017-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,356 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
